Clinical Trial Update: OVATIO CRT and SITUS OTW LV Lead Post Approval Study

View source ↗

Summary

Post-approval clinical trial update for OVATIO CRT and SITUS OTW LV Lead in heart failure; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OVATIO CRT
• SITUS OTW LV Lead

Snippet

Sponsor: ELA Medical, Inc. | Conditions: Heart Failure | Status: COMPLETED